A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults

Exclusion Criteria

• •1. Have taken an investigational drug within 30 days or 5 half-lives, if known, (whichever is longer) prior to screening.
• •2. Have had prior exposure to SEP-380135.
• •3. Are currently participating in another clinical trial.
• •4. Attempted suicide within 12 months prior to screening.
• •5. A history of sick sinus syndrome, any degree of atrioventricular block, Heart attack (myocardial infarction), heart failure (NYHA Class II-IV), cardiomyopathy, pulmonary congestion, cardiac arrhythmias, prolonged QT interval, congenital long QT syndrome, family history of long QT, or moderate to severe hypokalemia. A participant with non-clinically significant ECG abnormalities at screening and check-in requires approval from the medical monitor and the sponsor's physician.